+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Trends in medicare spending for injectable drugs



Trends in medicare spending for injectable drugs



Journal of the American Society of Nephrology 14(Abstracts Issue): 256A




(PDF emailed within 1 workday: $29.90)

Accession: 035985421

Download citation: RISBibTeXText



Related references

Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007. Journal of Managed Care Pharmacy 13(9): 799-806, 2007

Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11. Health Affairs 33(11): 2018-2024, 2016

Trends in Medicare spending on topical immunomodulators and chemotherapies. Journal of the American Academy of Dermatology 78(1): 173-175, 2018

Medicare and Medicaid spending trends and the deficit debate. New England Journal of Medicine 367(5): 393-395, 2012

Trends and Characteristics of US Medicare Spending on Repository Corticotropin. JAMA Internal Medicine 177(11): 1680-1682, 2017

Understanding Trends in Medicare Spending, 2007-2014. Health Services Research 53(5): 3507-3527, 2018

Long-term trends in the concentration of Medicare spending. Health Affairs 26(3): 808-816, 2007

Trends in Medicare spending on topical immunomodulators and chemotherapies. Journal of the American Academy of Dermatology 78(1): 173-175, 2018

Medicare and private spending trends from 2008 to 2012 diverge in Texas. Medical Care Research and Review 72(1): 96-112, 2016

National trends in out-of-pocket prescription drug spending among elderly medicare beneficiaries. Expert Review of Pharmacoeconomics and Outcomes Research 5(3): 297-315, 2005

Trends In Medicare Fee-For-Service Spending Growth For Dual-Eligible Beneficiaries, 2007-15. Health Affairs 37(8): 1265-1273, 2018

Limits on Medicare's ability to control rising spending on cancer drugs. New England Journal of Medicine 360(6): 626-633, 2009

Negative Medicare spending trends impact patient care, Scully tells Senate panel. Hospital Outlook 2(5): 1-2, 12, 1999

Looking inside the nation's medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001. Health Affairs 23(5): 217-225, 2004

Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries. Arthritis Care and Research 67(9): 1210-1218, 2016